By Joseph Juan, Dimitre Simeonov, Katherine Woronowicz, Henok Eyob, Ph.D., Armen Mekhjian, and Evan Markegard
Overview of Cancer Immunotherapy
The buzz may be all about cancer immunotherapy this year, but this area of research has roots in experiments over 120 years old. A doctor named William Coley was the first to guide the power of the immune system to target his patients' inoperable tumors. He injected his patients' tumors with streptococcus bacteria in order to trigger a fierce immune response and subsequent regression of the targeted tumor.
Thanks to the fact that we no longer inject tumors with bacteria, interest in the field of immunotherapy is booming. Citigroup analyst Andrew Baum estimates that by 2023, immunotherapy will grow to a ...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|